AMSBIO launches new range of biosimilar antibodies for research use

AMSBIO has launched a new range of research grade biosimilars that enable analysis of biological processes without the need to purchase expensive therapeutic-grade biologics.

AMSBIO launches new range of biosimilar antibodies for research use
Image Credit: AMSBIO

Investigating the biological effects of a drug or doing proof of concept assay development, requires a source of the drug. Typically, it is difficult to obtain original pharmaceutical grade biotherapeutic drugs for research use, rather than a clinical application. Consequently, biological compounds almost identical to a reference biologic drug (biosimilars) that have been approved by governmental regulatory authorities for medical treatment are vital research tools.

To develop an effective biologic drug, it is important to synthesize a reference antibody. A reference antibody can greatly facilitate the downstream development of a new biologic drug and can help identify critical cell lines, reagents and performance characteristics. AMSBIO's new range of biosimilar antibodies for research use avoid the need to source an expensive therapeutic product and enable fast and inexpensive assay development.

One of the main challenges in analyzing the impact of biosimilars is obtaining a validated positive control for in-situ analysis. For this task - FFPE cytosections of HEK293T cell pellet that over-express targeted proteins are available from AMSBIO. These cells are obtained by transfection of a sequenced verified cDNA clones transfected into HEK293T cells and the expression is verified by western blot and IHC analysis.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AMS Biotechnology. (2021, November 10). AMSBIO launches new range of biosimilar antibodies for research use. AZoLifeSciences. Retrieved on January 22, 2022 from https://www.azolifesciences.com/news/20210715/AMSBIO-launches-new-range-of-biosimilar-antibodies-for-research-use.aspx.

  • MLA

    AMS Biotechnology. "AMSBIO launches new range of biosimilar antibodies for research use". AZoLifeSciences. 22 January 2022. <https://www.azolifesciences.com/news/20210715/AMSBIO-launches-new-range-of-biosimilar-antibodies-for-research-use.aspx>.

  • Chicago

    AMS Biotechnology. "AMSBIO launches new range of biosimilar antibodies for research use". AZoLifeSciences. https://www.azolifesciences.com/news/20210715/AMSBIO-launches-new-range-of-biosimilar-antibodies-for-research-use.aspx. (accessed January 22, 2022).

  • Harvard

    AMS Biotechnology. 2021. AMSBIO launches new range of biosimilar antibodies for research use. AZoLifeSciences, viewed 22 January 2022, https://www.azolifesciences.com/news/20210715/AMSBIO-launches-new-range-of-biosimilar-antibodies-for-research-use.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
You might also like... ×
Aptamers for Targeting SARS-CoV-2 Proteins